Facebook
Google+
LinkedIn
Seattle Genetics, Inc. - Seattle Genetics, Inc. develops monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases..
Management Information
CEO
Mr. Clay B. Siegall
Company Information
Est. Revenue: $9 Million
The contact, business and financial information provided above regarding Seattle Genetics, Inc. is believed to be factual and up-to-date, but BB101 does not guarantee its accuracy. In some cases, estimated revenue has been calculated based on employee count and industry statistics. The information on these manufacturers and service companies may have changed recently so please contact the business itself for further information and data. More Companies to Explore